BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16647138)

  • 1. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders.
    Phillis JW; Horrocks LA; Farooqui AA
    Brain Res Rev; 2006 Sep; 52(2):201-43. PubMed ID: 16647138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of inflammation in brain: a matter of fat.
    Farooqui AA; Horrocks LA; Farooqui T
    J Neurochem; 2007 May; 101(3):577-99. PubMed ID: 17257165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid-derived lipid mediators and blood platelet aggregation.
    Lagarde M; Chen P; Véricel E; Guichardant M
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):227-30. PubMed ID: 20207119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosanoid regulation of angiogenesis in tumors.
    Nie D; Honn KV
    Semin Thromb Hemost; 2004 Feb; 30(1):119-25. PubMed ID: 15034803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the molecular approach of COX and LOX in Alzheimer's and Parkinson's disorder.
    Kumar A; Behl T; Jamwal S; Kaur I; Sood A; Kumar P
    Mol Biol Rep; 2020 Dec; 47(12):9895-9912. PubMed ID: 33263931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid inflammatory mediators in diabetic vascular disease.
    Natarajan R; Nadler JL
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1542-8. PubMed ID: 15166011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of lipid mediators in kidney injury.
    Hao CM; Breyer MD
    Semin Nephrol; 2007 May; 27(3):338-51. PubMed ID: 17533010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of eicosanoids in the brain.
    Tassoni D; Kaur G; Weisinger RS; Sinclair AJ
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():220-8. PubMed ID: 18296342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.
    Minghetti L
    J Neuropathol Exp Neurol; 2004 Sep; 63(9):901-10. PubMed ID: 15453089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative metabolism of endocannabinoids.
    Kozak KR; Marnett LJ
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):211-20. PubMed ID: 12052037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans.
    Farooqui AA; Ong WY; Horrocks LA; Chen P; Farooqui T
    Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models.
    Bosetti F
    J Neurochem; 2007 Aug; 102(3):577-86. PubMed ID: 17403135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders.
    Farooqui AA
    Neuroscientist; 2009 Aug; 15(4):392-407. PubMed ID: 19666894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The arachidonic acid pathway and its role in prostate cancer development and progression.
    Patel MI; Kurek C; Dong Q
    J Urol; 2008 May; 179(5):1668-75. PubMed ID: 18343442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation, COX-2, and ALS--a dual role?
    Consilvio C; Vincent AM; Feldman EL
    Exp Neurol; 2004 May; 187(1):1-10. PubMed ID: 15081582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autacoids and some mediators in allergic and non allergic forms.
    Ghezzi E
    Boll Ist Sieroter Milan; 1986; 65(3):169-92. PubMed ID: 2877678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic Acid metabolites in the cardiovascular system: the role of lipoxygenase isoforms in atherogenesis with particular emphasis on vascular remodeling.
    Kuhn H; Chaitidis P; Roffeis J; Walther M
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):609-20. PubMed ID: 18091576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoxygenases and their involvement in programmed cell death.
    Maccarrone M; Melino G; Finazzi-Agrò A
    Cell Death Differ; 2001 Aug; 8(8):776-84. PubMed ID: 11526430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic and natural inhibitors of phospholipases A2: their importance for understanding and treatment of neurological disorders.
    Ong WY; Farooqui T; Kokotos G; Farooqui AA
    ACS Chem Neurosci; 2015 Jun; 6(6):814-31. PubMed ID: 25891385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?
    Fürstenberger G; Krieg P; Müller-Decker K; Habenicht AJ
    Int J Cancer; 2006 Nov; 119(10):2247-54. PubMed ID: 16921484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.